Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes
- 11 March 2016
- journal article
- review article
- Published by Springer Nature in Current Urology Reports
- Vol. 17 (5) , 1-6
Abstract
Patients diagnosed with stage I non-seminomatous germ cell tumor (NSGCT) face the task of selecting a management strategy. Whereas these options all offer excellent survival, unfortunately, each has drawbacks. Retroperitoneal lymph node dissection (RPLND) is a major operation with low, but significant risks of bleeding, chylous ascites, and retrograde ejaculation. Platinum-based chemotherapy is associated with a number of long-term side effects, not all of which are quantified, but include secondary malignancy and early cardiovascular disease. While surveillance minimizes the chances of exposure to unnecessary treatment, it is not infrequently salvaged with chemotherapy and requires a compliant patient willing to undergo serial imaging often with ionizing radiation. Although fewer than one-third of patients will relapse without intervention, the current guidelines propose treatment for stage I patients with high-risk features. New developments in minimally invasive techniques may mitigate the harms of RPLND and avoid the side effects of chemotherapy, making it an ideal option for this cohort of patients. Unlike laparoscopic RPLND, which was introduced as a staging procedure and heavily criticized for the advanced skill set required to achieve oncologic equivalence, robotic RPLND may offer the benefits of a minimally invasive technique without a steep learning curve and a true therapeutic operation in experienced hands.Keywords
This publication has 45 references indexed in Scilit:
- Global incidence and outcome of testicular cancerClinical Epidemiology, 2013
- Testicular cancer in Europe and the USA: survival still rising among older patientsAnnals of Oncology, 2012
- International Trends in the Incidence of Testicular Cancer, 1973-2002Cancer Epidemiology, Biomarkers & Prevention, 2010
- Estimating the Risk of Cancer Associated With Imaging Related Radiation During Surveillance for Stage I Testicular Cancer Using Computerized TomographyJournal of Urology, 2009
- Long-Term Results of Laparoscopic Retroperitoneal Lymph-Node Dissection for Clinical Stage I Nonseminomatous Germ-Cell Testicular CancerJournal of Endourology, 2007
- Laparoscopic and Open Retroperitoneal Lymph-Node Dissection for Clinical Stage I Nonseminomatous Germ-Cell Testis TumorsJournal of Endourology, 2006
- Increasing Incidence of Testicular Germ Cell Tumors Among Black Men in the United StatesJournal of Clinical Oncology, 2005
- Laparoscopic Retroperitoneal Lymph-Node Dissection in the Management of Clinical Stage I and II Testicular CancerJournal of Endourology, 2005
- Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on OutcomeJournal of Clinical Oncology, 2005
- Retroperitoneal Lymphadenectomy for Clinical Stage I Nonseminomatous Testicular Tumor: Laparoscopy Versus Open Surgery and Impact of Learning CurveJournal of Urology, 1996